These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 7752948)
1. The incidental finding of abnormal cervical histology in postmenopausal patients. Gerbaldo D; Cristoforoni P; Leone M; Casciaro L; Baracchini P; Fulcheri E Maturitas; 1995 Feb; 21(2):115-20. PubMed ID: 7752948 [TBL] [Abstract][Full Text] [Related]
2. Borderline nuclear abnormality in cervical smears: a cytological review of 200 cases with histological correlation. Stewart CJ; Livingstone D; Mutch AF Cytopathology; 1993; 4(6):339-45. PubMed ID: 8110973 [TBL] [Abstract][Full Text] [Related]
3. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153 [TBL] [Abstract][Full Text] [Related]
4. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus]. Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008 [TBL] [Abstract][Full Text] [Related]
5. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906 [TBL] [Abstract][Full Text] [Related]
6. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169 [TBL] [Abstract][Full Text] [Related]
10. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635 [TBL] [Abstract][Full Text] [Related]
11. Could HPV testing become the sole primary cervical screening test? Sasieni P; Cuzick J J Med Screen; 2002; 9(2):49-51. PubMed ID: 12133918 [No Abstract] [Full Text] [Related]
12. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681 [TBL] [Abstract][Full Text] [Related]
13. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Nobbenhuis MA; Walboomers JM; Helmerhorst TJ; Rozendaal L; Remmink AJ; Risse EK; van der Linden HC; Voorhorst FJ; Kenemans P; Meijer CJ Lancet; 1999 Jul; 354(9172):20-5. PubMed ID: 10406360 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population. McKinnon KJ; Ford RM; Hunter JC Int J STD AIDS; 1991; 2(4):276-9. PubMed ID: 1655057 [TBL] [Abstract][Full Text] [Related]
15. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Burk RD; Kadish AS; Calderin S; Romney SL Am J Obstet Gynecol; 1986 May; 154(5):982-9. PubMed ID: 3010725 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions. Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355 [TBL] [Abstract][Full Text] [Related]
18. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study. Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518 [TBL] [Abstract][Full Text] [Related]
19. HPV testing in primary screening of older women. Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785 [TBL] [Abstract][Full Text] [Related]
20. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral. Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]